| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Kenneth Galbraith
Also a director
Chief Executive Officer, President and Chair of Board of Directors
|
64 | Not stated | Not stated | $6,613,180 | |
|
Kristin Stafford
Executive Vice President and Chief Financial Officer
|
44 | Not stated | 2026 | Not reported | |
|
Paul A. Moore
Chief Scientific Officer
|
60 | Not stated | 2022 | $2,348,190 | |
|
Sabeen Mekan
Senior Vice President and Chief Medical Officer
|
47 |
Since 2026
this year
|
2025 | Not reported | |
|
Scott Platshon
Executive Vice President and Chief Business Officer
|
35 |
Since 2026
this year
|
Not stated | Not reported | |
|
Paul Schneider
Executive Vice President and General Counsel
|
56 | Not stated | Not stated | Not reported | |
|
Adam Schayowitz
Executive Vice President and Head of R&D
|
46 |
Since 2026
this year
|
Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Oct 26, 2026 states there were none.
Read it in the proxyLoading...